Stockscreener 앱 받기
1.22
4.27%
0.05
시장 영업 전:
1.22
전일 마감가:
$1.17
열려 있는:
$1.18
하루 거래량:
177.24K
Relative Volume:
1.31
시가총액:
$14.37M
수익:
$28.74M
순이익/손실:
$-31.60M
주가수익비율:
-0.2401
EPS:
-5.0805
순현금흐름:
$-19.30M
1주 성능:
+0.00%
1개월 성능:
+15.09%
6개월 성능:
+6.09%
1년 성능:
-67.64%
1일 변동 폭
$1.15
$1.22
1주일 범위
$1.15
$1.26
52주 변동 폭
$1.00
$5.50
바이오나노 지노믹스 Stock (BNGO) Company Profile
명칭
Bionano Genomics Inc
전화
(858) 888-7600
주소
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.22 | 14.25M | 28.74M | -31.60M | -19.30M | -5.0805 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
바이오나노 지노믹스 Stock (BNGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-15 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-12 | 재개 | BTIG Research | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2021-06-16 | 개시 | BTIG Research | Buy |
| 2020-09-24 | 개시 | Ladenburg Thalmann | Buy |
| 2020-04-08 | 개시 | Oppenheimer | Outperform |
모두보기
바이오나노 지노믹스 주식(BNGO)의 최신 뉴스
Bionano Genomics (NASDAQ: BNGO) interim CEO buys 4,000 shares - Stock Titan
Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest TradingLong-Term Guidance - vinanet.vn
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - qz.com
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript - AOL.com
Alex Reid Hastie Net Worth (2026) - GuruFocus
Bionano Genomics (BNGO) investor discloses 9.9% position via warrants - Stock Titan
Gossamer Bio: Q2 Earnings Snapshot - AOL.com
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bionano Reports Second Quarter 2026 Results and Provides a Business Update - Moomoo
Bionano Genomics earnings beat by $0.13, revenue topped estimates - Investing.com Nigeria
Bionano Genomics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-08-11 - Seeking Alpha
Bionano Genomics Q2 2026 Earnings Call Transcript - MarketBeat
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: - GuruFocus
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ... - Yahoo! Finance Canada
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Bionano Genomics Q2 Results: Revenue rises 21% to $8.2 million - scanx.trade
Bionano Genomics Q3 Results: Sales guidance ranges $8.200M-$8.600M - scanx.trade
BNGO Looks 21.6% Undervalued on GF Value™ Despite Unprofitabilit - GuruFocus
BIONANO GENOMICS ($BNGO) Releases Q2 2026 Earnings - Quiver Quantitative
How Could Bionano Genomics (NASDAQ:BNGO) Influence Penny Stocks Sentiment? - Kalkine Media
Bionano Genomics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints - TradingView
Is Bionano Genomics Inc (BNGO) Undervalued After Q2 Earnings? EPS: -$7.4M, Revenue: $8.2M, GF Score: 64/100 - GuruFocus
Transcript : Bionano Genomics, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
Earnings call transcript: Bionano Genomics tops Q2 revenue view, shares edge up - Investing.com
Bionano Genomics raises FY26 sales guidance range - scanx.trade
Q2 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano Genomics Q2 revenue rises on increased clinical adoption - TradingView
BNGO: Q2 2026 revenue rose 21% but liquidity concerns threaten ongoing operations - TradingView
Bionano Reports Q2 2026 Revenue of $8.2M, Gross Margin 53% - TradingView
Bionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary - TradingView
Bionano Genomics (NASDAQ: BNGO) grows revenue amid going concern warning - Stock Titan
BRIEF-Bionano Genomics Q2 Revenue USD 8.2 Million - TradingView
Bionano Genomics, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Bionano Genomics (NASDAQ:BNGO): What Could Today’s Update Reveal About Adoption And Liquidity Ahead Of The Update? - Kalkine Media
BNGO: Q2 2026 revenue rose 21% to $8.2M, with margin gains and raised full-year guidance - TradingView
Bionano Genomics | 8-K: Current report - Moomoo
BNGO Looks 22.1% Undervalued on GF Value™ - GuruFocus
Bionano Genomics, Inc. expected to post a loss of 68 cents a shareEarnings Preview - TradingView
Bionano Genomics Inc (BNGO) Stock News Today - TradingKey
BioNano Genomics Inc (0A4K) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
BioNano Genomics Inc (0A4K) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Value Sees 27% Upside - Yahoo Finance
BNGO Q2'26 Earnings: EPS estimate is (0.67) USD - TradingView
바이오나노 지노믹스 (BNGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
0.50%
자본화:
|
볼륨(24시간):